<DOC>
	<DOC>NCT01436032</DOC>
	<brief_summary>The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.</brief_summary>
	<brief_title>Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Planning to undergo elective abdominal laparoscopic surgery involving a single site/organ and does not have intraperitoneal metastases suspected or identified Use of ketorolac is contraindicated Use of general anesthesia is contraindicated Has a medical condition that could adversely impact subject participation Has diabetes mellitus and glycosylated hemoglobin (HbA1c) &gt;9.5 or history of prolonged uncontrolled diabetes Body mass index (BMI) less than 18 or greater than 35 Has a history of intolerance or allergic reactions to nonsteroidal antiinflammatory drugs (NSAIDs), Cox2 inhibitors, aspirin or other salicylates Known or suspected sleep apnea History of Hepatitis B or C Has a psychiatric disorder that impairs capability of subject to report pain Known to have chronic obstructive pulmonary disease (COPD) with carbon dioxide retention or chronic hypoxemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>